151 related articles for article (PubMed ID: 11092972)
1. A novel "Nihon" rat model of a Mendelian dominantly inherited renal cell carcinoma.
Okimoto K; Kouchi M; Kikawa E; Toyosawa K; Koujitani T; Tanaka K; Matsuoka N; Sakurai J; Hino O
Jpn J Cancer Res; 2000 Nov; 91(11):1096-9. PubMed ID: 11092972
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
Walker C; Ahn YT; Everitt J; Yuan X
Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
[TBL] [Abstract][Full Text] [Related]
5. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
[TBL] [Abstract][Full Text] [Related]
6. Natural history of the Nihon rat model of BHD.
Okimoto K; Kouchi M; Matsumoto I; Sakurai J; Kobayashi T; Hino O
Curr Mol Med; 2004 Dec; 4(8):887-93. PubMed ID: 15579036
[TBL] [Abstract][Full Text] [Related]
7. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
[TBL] [Abstract][Full Text] [Related]
8. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis of cancer of the kidney.
Linehan WM; Walther MM; Zbar B
J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
[TBL] [Abstract][Full Text] [Related]
10. A germ-line insertion in the Birt-Hogg-Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer.
Okimoto K; Sakurai J; Kobayashi T; Mitani H; Hirayama Y; Nickerson ML; Warren MB; Zbar B; Schmidt LS; Hino O
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2023-7. PubMed ID: 14769940
[TBL] [Abstract][Full Text] [Related]
11. Renal carcinogenesis: genotype, phenotype and dramatype.
Hino O; Kobayashi T; Momose S; Kikuchi Y; Adachi H; Okimoto K
Cancer Sci; 2003 Feb; 94(2):142-7. PubMed ID: 12708488
[TBL] [Abstract][Full Text] [Related]
12. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
13. [VHL gene and TSC 2 gene].
Hino O
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1386-91. PubMed ID: 9309130
[TBL] [Abstract][Full Text] [Related]
14. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
[TBL] [Abstract][Full Text] [Related]
15. TSC2 gene mutant (Eker) rat model of a Mendelian dominantly inherited cancer.
Hino O; Fukuda T; Satake N; Kobayashi T; Honda S; Orimoto K; Yamashita Y; Kikuchi Y
Prog Exp Tumor Res; 1999; 35():95-108. PubMed ID: 10377754
[No Abstract] [Full Text] [Related]
16. TSC1 and TSC2 gene mutations in human kidney tumors.
Kajino K; Hino O
Contrib Nephrol; 1999; 128():45-50. PubMed ID: 10597376
[No Abstract] [Full Text] [Related]
17. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
[TBL] [Abstract][Full Text] [Related]
19. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
[TBL] [Abstract][Full Text] [Related]
20. Presence of a modifier gene(s) affecting early renal carcinogenesis in the Tsc2 mutant (Eker) rat model.
Kikuchi Y; Sudo A; Mitani H; Hino O
Int J Oncol; 2004 Jan; 24(1):75-80. PubMed ID: 14654943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
